2 results
Approved WMORecruiting
To assess the safety and efficacy of the FANTOM ENCORE sirolimus-eluting BRS.
Approved WMOCompleted
Phase Ia: (dose escalation):- To determine the maximum tolerated dose (MTD) and a recommended Phase II dose (RP2D) for M3814 (also referred to as MSC2490484A) in combination with fractionated palliative radiotherapy (RT) for tumors or metastases…